Oslo - Delayed Quote NOK

PCI Biotech Holding ASA (PCIB.OL)

Compare
1.3200 -0.1000 (-7.04%)
At close: December 20 at 4:25:22 PM GMT+1
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
22,241.0000
22,241.0000
56,447.0000
86,029.0000
82,120.0000
Operating Income
-22,241.0000
-22,241.0000
-56,447.0000
-86,029.0000
-82,120.0000
Net Non Operating Interest Income Expense
1,927.0000
1,927.0000
1,352.0000
-2,362.0000
9,881.0000
Pretax Income
-20,315.0000
-20,315.0000
-55,095.0000
-88,391.0000
-72,239.0000
Net Income Common Stockholders
-20,315.0000
-20,315.0000
-55,095.0000
-88,391.0000
-72,239.0000
Diluted NI Available to Com Stockholders
-20,315.0000
-20,315.0000
-55,095.0000
-88,391.0000
-72,239.0000
Basic EPS
-0.54
--
-1.48
-2.37
-1.94
Diluted EPS
-0.54
--
-1.48
-2.37
-1.94
Basic Average Shares
37,326.0000
--
37,326.0000
37,326.0000
37,285.0000
Diluted Average Shares
37,326.0000
--
37,326.0000
37,326.0000
37,285.0000
Total Operating Income as Reported
-22,241.0000
-22,241.0000
-56,447.0000
-86,029.0000
-82,121.0000
Total Expenses
22,241.0000
22,241.0000
56,447.0000
86,029.0000
82,120.0000
Net Income from Continuing & Discontinued Operation
-20,315.0000
-20,315.0000
-55,095.0000
-88,391.0000
-72,239.0000
Normalized Income
-20,315.0000
-20,315.0000
-55,095.0000
-88,391.0000
-72,239.0000
Interest Income
2,086.0000
2,086.0000
1,237.0000
640.0000
1,849.0000
Interest Expense
159.0000
159.0000
127.0000
89.0000
397.0000
Net Interest Income
1,927.0000
1,927.0000
1,352.0000
-2,362.0000
9,881.0000
EBIT
-20,156.0000
-20,156.0000
-54,968.0000
-88,302.0000
-71,842.0000
EBITDA
-19,785.0000
-19,785.0000
-48,562.0000
-85,761.0000
-69,634.0000
Reconciled Depreciation
371.0000
371.0000
6,406.0000
2,541.0000
2,208.0000
Net Income from Continuing Operation Net Minority Interest
-20,315.0000
-20,315.0000
-55,095.0000
-88,391.0000
-72,239.0000
Normalized EBITDA
-19,785.0000
-19,785.0000
-48,562.0000
-85,761.0000
-69,634.0000
12/31/2020 - 6/23/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CRNA.OL Circio Holding ASA
0.7080
-3.28%
 
LIDDS.ST LIDDS AB (publ)
0.1045
-0.95%
 
NANECH.ST NanoEcho AB
0.1580
+21.54%
 
QUIA.ST Quia Pharma AB (publ)
0.0172
+3.61%
 
BGBIO.OL BerGenBio ASA
8.35
-3.61%
 
COMBI.ST CombiGene AB (publ)
2.7200
+5.43%
 
DIABIO.ST Diagonal Bio AB (publ)
0.0258
+5.31%
 
ZICC.ST Ziccum AB (publ)
0.3830
-6.36%
 
NYKD.OL Nykode Therapeutics AS
2.8880
-3.41%
 
ULTI.OL Ultimovacs ASA
2.5500
-3.77%